Cognition Therapeutics Management
Management criteria checks 3/4
Cognition Therapeutics' CEO is Lisa Ricciardi, appointed in Mar 2020, has a tenure of 4.08 years. total yearly compensation is $1.01M, comprised of 54.2% salary and 45.8% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth $108.93K. The average tenure of the management team and the board of directors is 2.5 years and 3.1 years respectively.
Key information
Lisa Ricciardi
Chief executive officer
US$1.0m
Total compensation
| CEO salary percentage | 54.2% |
| CEO tenure | 4.1yrs |
| CEO ownership | 0.1% |
| Management average tenure | 2.5yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
Cognition Therapeutics: Approaching Phase 2 Readout In Alzheimer's
Apr 18Here's Why We're Watching Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Situation
Nov 30
Is Cognition Therapeutics (NASDAQ:CGTX) In A Good Position To Deliver On Growth Plans?
Aug 15Cognition Therapeutics (NASDAQ:CGTX) Is In A Good Position To Deliver On Growth Plans
Mar 17Cognition stock rises 12% on $2.14M grant from NIH for Alzheimer's study
Sep 27We Think Cognition Therapeutics (NASDAQ:CGTX) Can Afford To Drive Business Growth
Aug 12Cognition's Alzheimer's candidate demonstrates mechanism of action; shares soar
Aug 05We're Not Very Worried About Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Rate
Mar 19CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$26m |
| Sep 30 2023 | n/a | n/a | -US$23m |
| Jun 30 2023 | n/a | n/a | -US$23m |
| Mar 31 2023 | n/a | n/a | -US$24m |
| Dec 31 2022 | US$1m | US$550k | -US$21m |
| Sep 30 2022 | n/a | n/a | -US$24m |
| Jun 30 2022 | n/a | n/a | -US$22m |
| Mar 31 2022 | n/a | n/a | -US$19m |
| Dec 31 2021 | US$11m | US$409k | -US$16m |
| Sep 30 2021 | n/a | n/a | -US$12m |
| Jun 30 2021 | n/a | n/a | -US$10m |
| Mar 31 2021 | n/a | n/a | -US$9m |
| Dec 31 2020 | US$1m | US$287k | -US$12m |
Compensation vs Market: Lisa's total compensation ($USD1.01M) is above average for companies of similar size in the US market ($USD673.68K).
Compensation vs Earnings: Lisa's compensation has been consistent with company performance over the past year.
CEO
Lisa Ricciardi (63 yo)
4.1yrs
Tenure
US$1,014,539
Compensation
Ms. Lisa R. Ricciardi serves as Chief Executive Officer and President at Cognition Therapeutics, Inc. since March 2020 and serves as Director since March 2019. She serves as a Consultant of Davita RX. Ms....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 4.1yrs | US$1.01m | 0.14% $ 108.9k | |
| Chief Medical Officer and Head of R&D | 5yrs | US$636.27k | 0.028% $ 21.1k | |
| Chief Financial Officer | less than a year | no data | no data | |
| VP & Head of CMC | less than a year | no data | no data |
2.5yrs
Average Tenure
Experienced Management: CGTX's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 5.1yrs | US$1.01m | 0.14% $ 108.9k | |
| Independent Director | 2.4yrs | US$65.84k | 0.026% $ 19.5k | |
| Independent Chairman of the Board | 3.8yrs | US$127.34k | 0% $ 0 | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | 8.8yrs | US$56.84k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
3.1yrs
Average Tenure
62yo
Average Age
Experienced Board: CGTX's board of directors are considered experienced (3.1 years average tenure).